Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1801394
rs1801394
0.030 GeneticVariation BEFREE Our updated meta-analysis provided statistical evidence for the role of <i>MLLT10</i> rs12770228, <i>MTRR</i> rs1801394, and <i>MTHFR</i> rs1801131 in increased susceptibility to meningioma. 28405167

2017

dbSNP: rs1801394
rs1801394
0.030 GeneticVariation BEFREE Moreover, we found that MTRR A66G (rs1801394) variant genotypes was associated with increased risk of meni</span>ngioma and glioma (G vs. A: OR=1.11, P=0.020; GG vs. AA+AG: OR=1.17, P=0.043; GG vs. AA: OR=1.22, P=0.023). 28915669

2017

dbSNP: rs1801394
rs1801394
0.030 GeneticVariation BEFREE Our study suggested that MTHFR C677T and MTRR A66G variants may affect the risk of adult meningioma in Chinese Han population. 23959833

2013

dbSNP: rs4968451
rs4968451
0.020 GeneticVariation BEFREE The polymorphisms rs4968451T>G in BRIP1 were significantly associated with the risk of meningioma (TT vs. TG vs. GG additive, P = 0.005; TT+TG vs. GG dominant, P = 0.015; TT/GT+GG recessive, P = 0.034). 29581016

2018

dbSNP: rs12770228
rs12770228
0.020 GeneticVariation BEFREE Our updated meta-analysis provided statistical evidence for the role of <i>MLLT10</i> rs12770228, <i>MTRR</i> rs1801394, and <i>MTHFR</i> rs1801131 in increased susceptibility to meningioma. 28405167

2017

dbSNP: rs1801131
rs1801131
0.020 GeneticVariation BEFREE In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults. 28915669

2017

dbSNP: rs1801131
rs1801131
0.020 GeneticVariation BEFREE Our updated meta-analysis provided statistical evidence for the role of <i>MLLT10</i> rs12770228, <i>MTRR</i> rs1801394, and <i>MTHFR</i> rs1801131 in increased susceptibility to meningioma. 28405167

2017

dbSNP: rs1045485
rs1045485
0.020 GeneticVariation BEFREE The CASP8 D302H polymorphism genotypic frequencies were not statistically significantly different between meningioma cases and controls, with frequencies of GG, GC and CC genotypes of 71.2%, 19,2% and 9.6%; and 57.9%, 36.8% and 5.3%, respectively. 26359420

2016

dbSNP: rs12770228
rs12770228
0.020 GeneticVariation BEFREE The variant 'A' allele in MLLT10 rs12770228 was associated with an increased risk of meningioma (per allele odds ratio: 1.25; 95% confidence interval: 1.02, 1.53; P=0.031). 24755950

2015

dbSNP: rs1045485
rs1045485
0.020 GeneticVariation BEFREE We tested the hypothesis that the CASP8 polymorphism D302H may influence risk of meningioma through analysis of five independent series of case patients and controls (n=631 and 637, respectively). 18823701

2009

dbSNP: rs4968451
rs4968451
0.020 GeneticVariation BEFREE We have identified a novel association between rs4968451 and meningioma risk. 18270339

2008

dbSNP: rs10936599
rs10936599
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs150766139
rs150766139
0.010 GeneticVariation BEFREE The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas. 31227763

2019

dbSNP: rs2235544
rs2235544
0.010 GeneticVariation BEFREE The C-allele of the DI01 SNP rs2235544 was related to increased circulating free T3/ free T4 ratio in glioma and meningioma patients, indicating greater T4 to T3 conversion. 31452060

2019

dbSNP: rs2736100
rs2736100
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs3731249
rs3731249
0.010 GeneticVariation BEFREE We report an undescribed p.(Ala148Thr) CDKN2A mutation in meningioma that was only present in relapsing tumors. 31729637

2019

dbSNP: rs603965
rs603965
0.010 GeneticVariation BEFREE Moreover, in stratified analyses by type of disease, we noticed that the rs603965 polymorphism was significantly associated with the susceptibility to glioma, but such positive results were not detected in pituitary adenoma or meningioma. 30972946

2019

dbSNP: rs9420907
rs9420907
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs2686876
rs2686876
0.010 GeneticVariation BEFREE We identified a new susceptibility locus for meningioma at 11p15.5 (rs2686876, odds ratio = 1.44, P = 9.86 × 10-9). 29762745

2018

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults. 28915669

2017

dbSNP: rs1243180
rs1243180
0.010 GeneticVariation BEFREE We genotyped two tightly linked single-nucleotide polymorphisms (SNPs) at MLLT10 associated with meningioma (rs12770228) or ovarian cancer (rs1243180), and tested for associations among 295 meningioma cases, 606 glioma cases and 646 noncancer controls, all of European descent. 24755950

2015

dbSNP: rs1217691063
rs1217691063
0.010 GeneticVariation BEFREE The current meta-analysis firstly provides evidence that the MTHFR C677T polymorphism may modify the risk for brain tumors, particularly meningioma. 23846816

2013

dbSNP: rs267606541
rs267606541
AIP
0.010 GeneticVariation BEFREE Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor. 22527616

2012

dbSNP: rs11012732
rs11012732
0.010 GeneticVariation BEFREE We identified a new susceptibility locus for meningioma at 10p12.31 (MLLT10, rs11012732, odds ratio = 1.46, P(combined) = 1.88 × 10(-14)). 21804547

2011

dbSNP: rs1035938
rs1035938
0.010 GeneticVariation BEFREE We observed significantly increased risk of meningioma with the T variant of GLTSCR1 rs1035938 (OR(CT/TT) = 3.5; 95% confidence interval: 1.8-6.9; P(trend) .0006), which persisted after controlling for multiple comparisons (P = .019). 20150366

2010